124 related articles for article (PubMed ID: 9109439)
21. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
22. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
[TBL] [Abstract][Full Text] [Related]
23. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer.
Bärlund M; Monni O; Weaver JD; Kauraniemi P; Sauter G; Heiskanen M; Kallioniemi OP; Kallioniemi A
Genes Chromosomes Cancer; 2002 Dec; 35(4):311-7. PubMed ID: 12378525
[TBL] [Abstract][Full Text] [Related]
24. Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells.
Ludwig A; Dietel M; Lage H
Anticancer Res; 2002; 22(6A):3213-21. PubMed ID: 12530067
[TBL] [Abstract][Full Text] [Related]
25. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
26. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
27. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
28. Homogeneously staining region in anthracycline-resistant HL-60/AR cells not associated with MDR1 amplification.
Gervasoni JE; Taub RN; Yu MT; Warburton D; Sabbath M; Gilleran S; Coppock DL; D'Alessandri J; Krishna S; Rosado M
Cancer Res; 1992 Oct; 52(19):5244-9. PubMed ID: 1394128
[TBL] [Abstract][Full Text] [Related]
29. [Gene amplification in murine leukemia cells with multiple drug resistance acquired in vivo].
Demidova NS; Goncharova SA; Chernova OB; Kopnin BP; Gudkov AV
Genetika; 1987 Oct; 23(10):1797-806. PubMed ID: 3692152
[TBL] [Abstract][Full Text] [Related]
30. Use of internally controlled reverse transcriptase-polymerase chain reaction for absolute quantitation of individual multidrug resistant gene transcripts in tissue samples.
Zhang F; Riley J; Gant TW
Electrophoresis; 1996 Jan; 17(1):255-60. PubMed ID: 8907550
[TBL] [Abstract][Full Text] [Related]
31. [The karyotypic variability of Chinese hamster CHLV-79 RJK cells characterized by multiple drug resistance resulting from the amplification of the mdr gene family].
Grinchuk TM; Lipskaia LA; Artsybasheva IV; Sorokina EA; Pan'shina IuT; Ignatova TN
Tsitologiia; 1996; 38(2):161-72. PubMed ID: 8754132
[TBL] [Abstract][Full Text] [Related]
32. Aberrant transcription from an unrelated promoter can result in MDR-1 expression following drug selection in vitro and in relapsed lymphoma samples.
Huff LM; Wang Z; Iglesias A; Fojo T; Lee JS
Cancer Res; 2005 Dec; 65(24):11694-703. PubMed ID: 16357181
[TBL] [Abstract][Full Text] [Related]
33. [Gene amplification and chromosomal rearrangements during acquisition of cellular resistance to the antimetabolite coformycin].
Debatisse M; Toledo F; Buttin G
Bull Cancer; 1994 May; 81(5):372-80. PubMed ID: 7749213
[TBL] [Abstract][Full Text] [Related]
34. Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.
de Silva M; Kantharidis P; Wall DM; Campbell L; Vrazas V; Nadalin G; Kaczmarczyk SJ; Hu XF; Parkin JD; Zalcberg JR
Br J Cancer; 1996 Jan; 73(2):169-74. PubMed ID: 8546902
[TBL] [Abstract][Full Text] [Related]
35. Characterization of gene rearrangements leading to activation of MDR-1.
Huff LM; Lee JS; Robey RW; Fojo T
J Biol Chem; 2006 Dec; 281(48):36501-9. PubMed ID: 16956878
[TBL] [Abstract][Full Text] [Related]
36. TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
Soman NR; Wogan GN; Rhim JS
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):738-42. PubMed ID: 2300559
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.
Mickley LA; Lee JS; Weng Z; Zhan Z; Alvarez M; Wilson W; Bates SE; Fojo T
Blood; 1998 Mar; 91(5):1749-56. PubMed ID: 9473242
[TBL] [Abstract][Full Text] [Related]
38. [Is MDR 1 gene responsible for multidrug-resistance in cancer cells?].
Ueda K
Tanpakushitsu Kakusan Koso; 1988 Jul; 33(8):1287-99. PubMed ID: 3067257
[No Abstract] [Full Text] [Related]
39. Simplified method for selective amplification and direct sequencing of cDNAs.
Gorman KB; Steinberg RA
Biotechniques; 1989 Apr; 7(4):326-8, 331. PubMed ID: 2483508
[No Abstract] [Full Text] [Related]
40. Chromosome rearrangement, oncogene activation, and other clonal events in cancer: their use in molecular diagnostics.
Wiedemann LM; McCarthy KP; Chan LC
J Pathol; 1991 Jan; 163(1):7-12. PubMed ID: 2002425
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
